Explore Savara Inc. Common Stock (SVRA) 2025, 2030, and 2040 uncovering promising investment opportunities in the dynamic world of low-priced stocks. Discover potential gems and make informed decisions for your investment portfolio with these budget-friendly options.
Based on latest analysts price prediction and SVRA Stock Forecast 2025 is $13.00, 2030 is $35.50, and $50.50 in 2040.
Based on latest Savara Inc. (SVRA)Â stock quote performance with an opening price at $3.78 with a 52 week high of $3.82 and a low of $3.76 and 1 year SVRA price target $6.25. The market capitalization stands at 508.88M. The 52-week range extends from a high of 4.21 to a low of 1.41.
About Savara Inc. Common Stock (SVRA)
Savara Inc. (NASDAQ: SVRA)is a clinical-stage biopharmaceutical company with a dedicated focus on rare respiratory diseases. At the forefront of their endeavors is molgramostim nebulizer solution, an inhaled biologic in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). This innovative treatment utilizes recombinant human GM-CSF, administered through the eFlow Nebulizer System.
The company is actively advancing the molgramostim aPAP program, with a particular emphasis on the Phase III IMPALA-2 clinical trial, while strategically outsourcing capital-intensive operations. Pulmonary alveolar proteinosis, the targeted rare lung disease, involves the accumulation of surfactant in the alveoli, making Savara’s work crucial in addressing unmet medical needs.
Savara Inc. (SVRA) Financial Analysis
| Quarterly Financials (USD) | Sep 2023 | Y/Y |
|---|---|---|
| Revenue | – | – |
| Net Income | -$16.6M | +59.82% |
| Diluted EPS | – | – |
| 1 Year Target | $6.25 | |
| Net Profit Margin | – | – |
RATIOS/PROFITABILITY
| Metric | Value |
|---|---|
| EPS (TTM) | -0.31 |
| P/E (TTM) | -11.67 |
| Forward P/E (NTM) | -9.90 |
| EBITDA (TTM) | -$53.199M |
| ROE (TTM) | -37.18% |
| Revenue (TTM) | – |
| Gross Margin (TTM) | – |
| Net Margin (TTM) | -4,544,500.00% |
| Debt To Equity (MRQ) | 17.93% |
Explore Realted multibagger Stocks that can make you rich in future: Can AMD Stock Reach $200 per Share Growth | Nugget Rush (NUGX) is all set to Outperform Bitcoin and Solana in 2023 | Microsoft Stock
SVRA Stock Forecast
Savara Inc. (SVRA) Stock Forecast predicted by 5 analysts have a median 12-month price target of $6.70, reaching a high estimate of $7.99 and a low estimate of $5.05 from the current price.
Savara Inc. (SVRA) Stock Forecast 2024
According to latest analysis SVRA Stock forecast for 2024 is expected to reach $4.30 in January and may reach a high Price target of $6.00 by December 15, the end of year 2024 from its current price of $3.64 in 2023
SVRA Stock Forecast 2025
SVRA| Savara stock price prediction based on 3 analysts for SVRA Stock Forecast 2025 is expected to reach a median price target of $9.90 and may reach $13.00 with a low estimate of $8.00 from its latest price.
Savara Inc. (SVRA) Stock Forecast 2030
SVRA: NASDAQ | Savara Stock price Forecast 2030 according to latest analysis is predicted to have a high target of $35.50 and low price of $25.00 with an average price of $29.00 from its last price.
Is svra a good stock to buy?
Savara Inc. (SVRA) Stock receives a favorable outlook as STRONG BUY both short and long-term Moving Averages indicate a positive forecast. Currently holding a Zacks Rank 4, the company enjoys a Strong Buy consensus in its analyst ratings, backed by assessments from three Wall Street analysts.
is svra a good stock to buy Now?
YES, SVRA holds a Zacks Rank 4 with strong analyst consensus, supported by positive short and long-term Moving Averages.
What is SVRA Stock Price prediction 2025?
Based on cuttent analysis SVRA Stock forecast 2025 have a median price target of $10.00 with a high price of $13.00
How do analysts view Savara Inc.’s stock?
The analyst consensus for Savara Inc. is a Strong Buy, based on assessments from three Wall Street analysts.
What is current market cap of Savara Inc. (SVRA) stock ?
The market capitalization stands at 508.88M based on latest information.
